Twist Bioscience is mentioned as a company that will benefit from the AI biotech trend.
Source Post
The creator discusses the potential of AI in biotech, specifically highlighting Moderna's recent advancemen...
Aug 20, 2026
The creator discusses the potential of AI in biotech, specifically highlighting Moderna's recent advancements in cancer vaccines. While bullish on the sector, the creator advises waiting for a pullback before buying Moderna and Tempus.
Linked Mentions
Tickers discussed in this post
The creator is bullish on the long-term AI biotech thesis but advises against buying Moderna at current levels, suggesting a wait for a price cool-down.
Linked Signals
Tracked calls opened from this post
MRNAsell opened Aug 20, 2026
+17.44%